These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Targeting human liver cancer cells with lactobionic acid-G(4)-PAMAM-FITC sorafenib loaded dendrimers. Iacobazzi RM; Porcelli L; Lopedota AA; Laquintana V; Lopalco A; Cutrignelli A; Altamura E; Di Fonte R; Azzariti A; Franco M; Denora N Int J Pharm; 2017 Aug; 528(1-2):485-497. PubMed ID: 28624661 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer. Oddone N; Lecot N; Fernández M; Rodriguez-Haralambides A; Cabral P; Cerecetto H; Benech JC J Nanobiotechnology; 2016 Jun; 14(1):45. PubMed ID: 27297021 [TBL] [Abstract][Full Text] [Related]
7. A self-internalizing mitochondrial TSPO targeting imaging probe for fluorescence, MRI and EM. Samuelson LE; Anderson BM; Bai M; Dukes MJ; Hunt CR; Casey JD; Han Z; Papadopoulos V; Bornhop DJ RSC Adv; 2014; 4(18):9003-9011. PubMed ID: 32051760 [TBL] [Abstract][Full Text] [Related]
8. Surface conjugation of triphenylphosphonium to target poly(amidoamine) dendrimers to mitochondria. Biswas S; Dodwadkar NS; Piroyan A; Torchilin VP Biomaterials; 2012 Jun; 33(18):4773-82. PubMed ID: 22469294 [TBL] [Abstract][Full Text] [Related]
9. Targeting cancer cells with biotin-dendrimer conjugates. Yang W; Cheng Y; Xu T; Wang X; Wen LP Eur J Med Chem; 2009 Feb; 44(2):862-8. PubMed ID: 18550227 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic and diagnostic applications of dendrimers for cancer treatment. Wolinsky JB; Grinstaff MW Adv Drug Deliv Rev; 2008 Jun; 60(9):1037-55. PubMed ID: 18448187 [TBL] [Abstract][Full Text] [Related]
11. Highly selective luminescent nanostructures for mitochondrial imaging and targeting. Fanizza E; Iacobazzi RM; Laquintana V; Valente G; Caliandro G; Striccoli M; Agostiano A; Cutrignelli A; Lopedota A; Curri ML; Franco M; Depalo N; Denora N Nanoscale; 2016 Feb; 8(6):3350-61. PubMed ID: 26763470 [TBL] [Abstract][Full Text] [Related]
12. Novel irreversible fluorescent probes targeting the 18 kDa translocator protein: synthesis and biological characterization. Taliani S; Da Pozzo E; Bellandi M; Bendinelli S; Pugliesi I; Simorini F; La Motta C; Salerno S; Marini AM; Da Settimo F; Cosimelli B; Greco G; Novellino E; Martini C J Med Chem; 2010 May; 53(10):4085-93. PubMed ID: 20438080 [TBL] [Abstract][Full Text] [Related]
13. Octreotide-conjugated PAMAM for targeted delivery to somatostatin receptors over-expressed tumor cells. Peng J; Qi X; Chen Y; Ma N; Zhang Z; Xing J; Zhu X; Li Z; Wu Z J Drug Target; 2014 Jun; 22(5):428-38. PubMed ID: 24437350 [TBL] [Abstract][Full Text] [Related]
14. Intrinsically fluorescent PAMAM dendrimer as gene carrier and nanoprobe for nucleic acids delivery: bioimaging and transfection study. Tsai YJ; Hu CC; Chu CC; Imae T Biomacromolecules; 2011 Dec; 12(12):4283-90. PubMed ID: 22029823 [TBL] [Abstract][Full Text] [Related]
15. DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacologic characterization. James ML; Fulton RR; Vercoullie J; Henderson DJ; Garreau L; Chalon S; Dolle F; Costa B; Guilloteau D; Kassiou M J Nucl Med; 2008 May; 49(5):814-22. PubMed ID: 18413395 [TBL] [Abstract][Full Text] [Related]
16. Dendrimer internalization and intracellular trafficking in living cells. Albertazzi L; Serresi M; Albanese A; Beltram F Mol Pharm; 2010 Jun; 7(3):680-8. PubMed ID: 20394437 [TBL] [Abstract][Full Text] [Related]
17. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality. Majoros IJ; Myc A; Thomas T; Mehta CB; Baker JR Biomacromolecules; 2006 Feb; 7(2):572-9. PubMed ID: 16471932 [TBL] [Abstract][Full Text] [Related]
18. Cellular uptake of glucoheptoamidated poly(amidoamine) PAMAM G3 dendrimer with amide-conjugated biotin, a potential carrier of anticancer drugs. Uram Ł; Szuster M; Filipowicz A; Zaręba M; Wałajtys-Rode E; Wołowiec S Bioorg Med Chem; 2017 Jan; 25(2):706-713. PubMed ID: 27919613 [TBL] [Abstract][Full Text] [Related]
19. Targeted and pH-responsive delivery of doxorubicin to cancer cells using multifunctional dendrimer-modified multi-walled carbon nanotubes. Wen S; Liu H; Cai H; Shen M; Shi X Adv Healthc Mater; 2013 Sep; 2(9):1267-76. PubMed ID: 23447549 [TBL] [Abstract][Full Text] [Related]
20. Surface modified dendrimers: synthesis and characterization for cancer targeted drug delivery. Sharma A; Gautam SP; Gupta AK Bioorg Med Chem; 2011 Jun; 19(11):3341-6. PubMed ID: 21570304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]